FCAS
UTHR icon

First Command Advisory Services’s United Therapeutics UTHR Stock Holding History

First Command Advisory Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$593 – 1309
2026
Q1 		$593 Buy
+1
New +$498 ﹤0.01% 1057

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

First Command Advisory Services's UTHR Position: Q2 2026 in Review

First Command Advisory Services sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 1 share — an estimated $593 sold.

First Command Advisory Services first reported a position in UTHR in Q1 2026 and held it in 1 quarter. The position peaked at $593 in Q1 2026. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • First Command Advisory Services reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • First Command Advisory Services sold 1 United Therapeutics share in Q2 2026, an estimated $593.
  • First Command Advisory Services first reported a position in United Therapeutics in Q1 2026 and held it in 1 quarter.
  • First Command Advisory Services's United Therapeutics position peaked at $593 in Q1 2026.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.